MannKind Corporation

MannKind Corporation

BioNJ Member Type: Core

A biopharmaceutical company that focuses on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. The Company’s lead investigational product candidate, AFRESA®, is an ultra rapid-acting insulin drug. MannKind Corporation specializes in developing innovative technologies that enable pulmonary delivery of medicine. We strive to help bring medicinal concepts to market in the form of sensible, patient-friendly treatment solutions.


61 S. Paramus Road Mack-Cali Ct.1V 5th floor
Paramus, NJ 07652